Targeting TORC1/2 Enhances Sensitivity to EGFR Inhibitors in Head and Neck Cancer Preclinical Models

Por Cassell, Andre, Freilino, Maria L, Lee, Jessica, Barr, Sharon, Wang, Lin, Panahandeh, Mary C, Thomas, Sufi M, Grandis, Jennifer R
Publicado em 2012

TARGETING STAT3 ABROGATES EGFR INHIBITOR RESISTANCE IN CANCER

Por Sen, Malabika, Joyce, Sonali, Panahandeh, Mary, Li, Changyou, Thomas, Sufi M., Maxwell, Jessica, Wang, Lin, Gooding, William E., Johnson, Daniel E., Grandis, Jennifer R.
Publicado em 2012

Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma

Por Leeman-Neill, Rebecca J., Seethala, Raja R., Singh, Shivendra V., Freilino, Maria L., Bednash, Joseph S., Thomas, Sufi M., Panahandeh, Mary C., Gooding, William E., Joyce, Sonali C., Lingen, Mark W., Neill, Daniel B., Grandis, Jennifer R.
Publicado em 2010

Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3

Por Leeman-Neill, Rebecca J., Wheeler, Sarah E., Singh, Shivendra V., Thomas, Sufi M., Seethala, Raja R., Neill, Daniel B., Panahandeh, Mary C., Hahm, Eun-Ryeong, Joyce, Sonali C., Sen, Malabika, Cai, Quan, Freilino, Maria L., Li, Changyou, Johnson, Daniel E., Grandis, Jennifer R.
Publicado em 2009